The Micron team recently attended the World Vaccine Congress Europe 2025, where leaders across the vaccine ecosystem gathered to share ideas, explore innovation, and discuss the future of global immunisation.

Across the event, presentations covered a wide range of topics — from the latest vaccine technologies and regulatory updates to new approaches in clinical development. The sessions were insightful and informative, providing valuable context for the evolving needs of vaccine research.

While this year’s congress featured a strong presence of clinical research organisations (CROs) and technical service providers, it also provided an excellent opportunity to strengthen industry awareness of Micron’s capabilities and explore new collaborations. Our team established several meaningful connections that may support patient recruitment and operational delivery for future vaccine studies.

Events like the World Vaccine Congress remain an important part of Micron’s engagement strategy — not only as a platform to showcase our experience but also as a space to listen, learn, and build relationships that advance clinical research together.

We extend our thanks to the organisers, fellow exhibitors, and everyone who visited our booth. It was a pleasure to connect, exchange ideas, and contribute to the ongoing conversation about how to bring vaccines from research to reality.

We’re already looking forward to next year’s World Vaccine Congress, and to continuing the conversations and collaborations that help shape the future of vaccine development.